The gene expression market size has grown rapidly in recent years. It will grow from $11.55 billion in 2024 to $12.79 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increasing focus on precision medicine, rise in cancer research and biomarker discovery, application in disease diagnosis and prognosis, integration with systems biology approaches, drug discovery and development needs.
The gene expression market size is expected to see rapid growth in the next few years. It will grow to $20.25 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to emergence of spatial transcriptomics, rise in epigenomic studies, global health events and pandemic preparedness, focus on non-coding rna exploration, increased utilization in immunotherapy research. Major trends in the forecast period include single-cell RNA sequencing, advancements in next-generation sequencing, integration of multi-omics data, advancements in gene editing technologies, liquid biopsy development, and spatial omics in drug discovery.
The growing emphasis on precision medicine is anticipated to drive the expansion of the gene expression market in the future. Precision medicine utilizes information about an individual's genes or proteins to diagnose, prevent, or treat diseases. Gene expression plays a vital role in precision medicine by identifying abnormalities in normal function and physiological regulation through the measurement and comparison of genes and transcripts in tissues across different medical conditions, enabling patient-centric treatment. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines constituted 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently maintained at least a quarter of new drug approvals over the past eight years, marking a significant rise from under 10% a decade earlier. Thus, the increased focus on precision medicine is propelling the gene expression market.
The increase in chronic diseases is expected to drive the growth of the gene expression market in the coming years. Chronic diseases are long-term medical conditions that last for an extended period, typically three months or longer. Gene expression analysis is employed in the context of chronic diseases to comprehend the molecular mechanisms behind these conditions, identify potential biomarkers, and develop targeted therapies. For example, in June 2022, data from Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Thus, the increase in chronic diseases will fuel the growth of the gene expression market.
Technological advancement stands out as a notable trend in the gene expression market, with major companies progressing towards RNA gene expression technology. For instance, in September 2022, Enzo Biochem, Inc., introduced AMPIVIEW, a new platform leveraging RNA gene expression technology for superior sensitivity in detecting and visualizing biomarkers in cells and tissue samples, specifically targeting HPV and SARS-CoV-2.
Major companies in the gene expression market are concentrating on innovative product development, such as gene detection assays, to gain a competitive edge and enhance revenue. Gene detection assays involve methods for identifying and quantifying the presence of genetic molecules, offering insights into the activity and abundance of specific genes. In January 2023, Bio-Techne Corporation expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This assay allows simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution.
In January 2023, Qiagen NV, a molecular testing solutions company based in Germany, acquired Verogen for an undisclosed sum. This acquisition allows Qiagen to fully access Verogen's innovative GEDmatch database and GEDmatch PRO portal, as well as exclusive distribution rights for the MiSeq sequencer specifically designed for forensic applications. Verogen is a US-based developer of DNA-based biometric human identification products.
Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation.
North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gene expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Gene expression is the process through which the information encoded in a gene is utilized to produce a functional product, typically a protein. This process directs the assembly of protein molecules, and the resulting proteins play a critical role in determining cell function.
The primary products associated with gene expression include kits and reagents, DNA chips or microarrays, and others. Kits and reagents are testing kits employed to detect specific substances either in a laboratory or in the field. The major processes involved in gene expression include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation. Techniques related to gene expression encompass RNA expression, promoter analysis, protein expression, and posttranslational modification analysis. These methods find applications in various fields such as drug discovery and development, clinical diagnostics, biotechnology, microbiology, and other related areas.
The gene expression market research report is one of a series of new reports that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The gene expression market size is expected to see rapid growth in the next few years. It will grow to $20.25 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to emergence of spatial transcriptomics, rise in epigenomic studies, global health events and pandemic preparedness, focus on non-coding rna exploration, increased utilization in immunotherapy research. Major trends in the forecast period include single-cell RNA sequencing, advancements in next-generation sequencing, integration of multi-omics data, advancements in gene editing technologies, liquid biopsy development, and spatial omics in drug discovery.
The growing emphasis on precision medicine is anticipated to drive the expansion of the gene expression market in the future. Precision medicine utilizes information about an individual's genes or proteins to diagnose, prevent, or treat diseases. Gene expression plays a vital role in precision medicine by identifying abnormalities in normal function and physiological regulation through the measurement and comparison of genes and transcripts in tissues across different medical conditions, enabling patient-centric treatment. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines constituted 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently maintained at least a quarter of new drug approvals over the past eight years, marking a significant rise from under 10% a decade earlier. Thus, the increased focus on precision medicine is propelling the gene expression market.
The increase in chronic diseases is expected to drive the growth of the gene expression market in the coming years. Chronic diseases are long-term medical conditions that last for an extended period, typically three months or longer. Gene expression analysis is employed in the context of chronic diseases to comprehend the molecular mechanisms behind these conditions, identify potential biomarkers, and develop targeted therapies. For example, in June 2022, data from Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Thus, the increase in chronic diseases will fuel the growth of the gene expression market.
Technological advancement stands out as a notable trend in the gene expression market, with major companies progressing towards RNA gene expression technology. For instance, in September 2022, Enzo Biochem, Inc., introduced AMPIVIEW, a new platform leveraging RNA gene expression technology for superior sensitivity in detecting and visualizing biomarkers in cells and tissue samples, specifically targeting HPV and SARS-CoV-2.
Major companies in the gene expression market are concentrating on innovative product development, such as gene detection assays, to gain a competitive edge and enhance revenue. Gene detection assays involve methods for identifying and quantifying the presence of genetic molecules, offering insights into the activity and abundance of specific genes. In January 2023, Bio-Techne Corporation expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This assay allows simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution.
In January 2023, Qiagen NV, a molecular testing solutions company based in Germany, acquired Verogen for an undisclosed sum. This acquisition allows Qiagen to fully access Verogen's innovative GEDmatch database and GEDmatch PRO portal, as well as exclusive distribution rights for the MiSeq sequencer specifically designed for forensic applications. Verogen is a US-based developer of DNA-based biometric human identification products.
Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation.
North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gene expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Gene expression is the process through which the information encoded in a gene is utilized to produce a functional product, typically a protein. This process directs the assembly of protein molecules, and the resulting proteins play a critical role in determining cell function.
The primary products associated with gene expression include kits and reagents, DNA chips or microarrays, and others. Kits and reagents are testing kits employed to detect specific substances either in a laboratory or in the field. The major processes involved in gene expression include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation. Techniques related to gene expression encompass RNA expression, promoter analysis, protein expression, and posttranslational modification analysis. These methods find applications in various fields such as drug discovery and development, clinical diagnostics, biotechnology, microbiology, and other related areas.
The gene expression market research report is one of a series of new reports that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Gene Expression Market Characteristics3. Gene Expression Market Trends and Strategies4. Gene Expression Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Gene Expression Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Gene Expression Market34. Recent Developments in the Gene Expression Market
5. Global Gene Expression Growth Analysis and Strategic Analysis Framework
6. Gene Expression Market Segmentation
7. Gene Expression Market Regional and Country Analysis
8. Asia-Pacific Gene Expression Market
9. China Gene Expression Market
10. India Gene Expression Market
11. Japan Gene Expression Market
12. Australia Gene Expression Market
13. Indonesia Gene Expression Market
14. South Korea Gene Expression Market
15. Western Europe Gene Expression Market
16. UK Gene Expression Market
17. Germany Gene Expression Market
18. France Gene Expression Market
19. Italy Gene Expression Market
20. Spain Gene Expression Market
21. Eastern Europe Gene Expression Market
22. Russia Gene Expression Market
23. North America Gene Expression Market
24. USA Gene Expression Market
25. Canada Gene Expression Market
26. South America Gene Expression Market
27. Brazil Gene Expression Market
28. Middle East Gene Expression Market
29. Africa Gene Expression Market
30. Gene Expression Market Competitive Landscape and Company Profiles
31. Gene Expression Market Other Major and Innovative Companies
35. Gene Expression Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Gene Expression Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on gene expression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gene expression ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene expression market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Kits and Reagents; DNA Chip or Microarray; Other Products2) by Process: Sample Collection; Purification; cDNA Synthesis and Conversion; PCR Analysis; Data Analysis and Interpretation
3) by Technique: RNA Exp; Promoter Analysis; Protein Exp. and Posttranslational Modification Analysis
4) by Application: Drug Discovery and Development; Clinical Diagnostics; Biotechnology and Microbiology; Other Applications
Subsegments:
1) by Kits and Reagents: RNA Isolation Kits; cDNA Synthesis Kits; qPCR Kits; Reverse Transcription Kits; Other Reagents2) by DNA Chip or Microarray: Expression Microarrays; Genotyping Microarrays; Comparative Genomic Hybridization Arrays;
3) by Other Products: Software For Data Analysis; Lab Instruments; Consumables
Key Companies Mentioned: Thermo Fisher Scientific Inc.; Qiagen NV; Illumina Inc.; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Gene Expression market report include:- Thermo Fisher Scientific Inc.
- Qiagen NV
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- PerkinElmer Inc.
- GE Healthcare
- F Hoffmann-La Roche Ltd
- Oxford Gene Technology IP Limited
- Promega Corporation
- OriGene Technologies Inc.
- Luminex Corporation
- Takara Bio Inc.
- Danaher Corporation
- ELITechGroup
- Biocartis Group NV
- Integragen SA
- Oxford Nanopore Technologies Limited
- Phalanx Biotech Group
- Roche Holding AG
- Sengenics Corporation Pte Ltd.
- GenXPro GmbH
- Twist Bioscience Corporation
- Zymo Research Corporation
- Abcam plc.
- Bio-Techne Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 12.79 Billion |
| Forecasted Market Value ( USD | $ 20.25 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
